BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37969214)

  • 1. Hemorrhagic pancreatitis from fenofibrate and metformin toxicity: a case report.
    Lee MAB; Ng M; Yugendra P; Yao Y; Ponampalam R; Tan BKK
    World J Emerg Med; 2023; 14(6):495-498. PubMed ID: 37969214
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatitis associated with simvastatin plus fenofibrate.
    McDonald KB; Garber BG; Perreault MM
    Ann Pharmacother; 2002 Feb; 36(2):275-9. PubMed ID: 11847949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate.
    Whitten AE; Lorenz RP; Smith JM
    Obstet Gynecol; 2011 Feb; 117(2 Pt 2):517-519. PubMed ID: 21252809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with metformin and fenofibrate for insulin resistance in obesity.
    Li XM; Li Y; Zhang NN; Xie YH; Shi YQ
    J Int Med Res; 2011; 39(5):1876-82. PubMed ID: 22117989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience.
    Kalina MA; Wilczek M; Kalina-Faska B; Skała-Zamorowska E; Mandera M; Małecka Tendera E
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):45-51. PubMed ID: 25536662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats.
    Oh TJ; Shin JY; Kang GH; Park KS; Cho YM
    Exp Mol Med; 2013 Jul; 45(7):e30. PubMed ID: 23827952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
    Pruski M; Krysiak R; Okopien B
    Diabetes Care; 2009 Aug; 32(8):1421-4. PubMed ID: 19435959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model--the Zucker diabetic rat.
    Forcheron F; Basset A; Abdallah P; Del Carmine P; Gadot N; Beylot M
    Cardiovasc Diabetol; 2009 Mar; 8():16. PubMed ID: 19317897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial.
    Wan Q; Wang F; Wang F; Guan Q; Liu Y; Wang C; Feng L; Gao G; Gao L; Zhao J
    Diabet Med; 2010 Nov; 27(11):1312-7. PubMed ID: 20968112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate.
    Forcheron F; Basset A; Del Carmine P; Beylot M
    Diabetes Metab; 2009 Dec; 35(6):452-7. PubMed ID: 19854668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.
    Krysiak R; Gdula-Dymek A; Okopień B
    Pharmacol Rep; 2013; 65(1):208-13. PubMed ID: 23563040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney].
    Wang W; Guo XH; Wu HH; Wang NH; Xu XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):170-5. PubMed ID: 16617360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: A rare case report and a review of the literature.
    Zhou J; Li D; Cheng Q
    Medicine (Baltimore); 2020 May; 99(21):e20390. PubMed ID: 32481339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin induced acute pancreatitis precipitated by renal failure.
    Mallick S
    Postgrad Med J; 2004 Apr; 80(942):239-40. PubMed ID: 15082849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance.
    Krysiak R; Gdula-Dymek A; Okopień B
    Pharmacol Rep; 2013; 65(2):429-34. PubMed ID: 23744427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model.
    Oidor-Chan VH; Hong E; Pérez-Severiano F; Montes S; Torres-Narváez JC; Del Valle-Mondragón L; Pastelín-Hernández G; Sánchez-Mendoza A
    PPAR Res; 2016; 2016():8237264. PubMed ID: 27069466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis.
    Kassim T; Hermes JM; Abdussalam A; Aly A; Chandra S
    Case Rep Gastrointest Med; 2018; 2018():4580860. PubMed ID: 30271638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.